Cyclic neutropenia: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 11: Line 11:
* Cyclic neutropenia is caused by a mutation in the ELA2 gene.<ref name="DaleBolyard2002">{{cite journal|last1=Dale|first1=David C.|last2=Bolyard|first2=Audrey Anna|last3=Aprikyan|first3=Andrew|title=Cyclic neutropenia|journal=Seminars in Hematology|volume=39|issue=2|year=2002|pages=89–94|issn=00371963|doi=10.1053/shem.2002.31917}}</ref><ref name="HorwitzCorey2013">{{cite journal|last1=Horwitz|first1=Marshall S.|last2=Corey|first2=Seth J.|last3=Grimes|first3=H. Leighton|last4=Tidwell|first4=Timothy|title=ELANE Mutations in Cyclic and Severe Congenital Neutropenia|journal=Hematology/Oncology Clinics of North America|volume=27|issue=1|year=2013|pages=19–41|issn=08898588|doi=10.1016/j.hoc.2012.10.004}}</ref>
* Cyclic neutropenia is caused by a mutation in the ELA2 gene.<ref name="DaleBolyard2002">{{cite journal|last1=Dale|first1=David C.|last2=Bolyard|first2=Audrey Anna|last3=Aprikyan|first3=Andrew|title=Cyclic neutropenia|journal=Seminars in Hematology|volume=39|issue=2|year=2002|pages=89–94|issn=00371963|doi=10.1053/shem.2002.31917}}</ref><ref name="HorwitzCorey2013">{{cite journal|last1=Horwitz|first1=Marshall S.|last2=Corey|first2=Seth J.|last3=Grimes|first3=H. Leighton|last4=Tidwell|first4=Timothy|title=ELANE Mutations in Cyclic and Severe Congenital Neutropenia|journal=Hematology/Oncology Clinics of North America|volume=27|issue=1|year=2013|pages=19–41|issn=08898588|doi=10.1016/j.hoc.2012.10.004}}</ref>
* The disease occurs in autosomal dominant mode of inheritance.
* The disease occurs in autosomal dominant mode of inheritance.
* Theoretically, this [[disorder]] can be cured by bone marrow transplantation. This demonstrates its pathogenesis as the stem cell abnormality.<ref name="pmid7036779">{{cite journal |vauthors=Lange RD, Jones JB |title=Cyclic neutropenia. Review of clinical manifestations and management |journal=Am J Pediatr Hematol Oncol |volume=3 |issue=4 |pages=363–7 |date=1981 |pmid=7036779 |doi= |url=}}</ref>
* This stem cell abnormality leads to the myelocyte maturation arrest during neutropenia episodes.
==Causes==
==Causes==
* Cyclic neutropenia is caused by a mutation in the ELA2 gene.<ref name="HorwitzCorey2013">{{cite journal|last1=Horwitz|first1=Marshall S.|last2=Corey|first2=Seth J.|last3=Grimes|first3=H. Leighton|last4=Tidwell|first4=Timothy|title=ELANE Mutations in Cyclic and Severe Congenital Neutropenia|journal=Hematology/Oncology Clinics of North America|volume=27|issue=1|year=2013|pages=19–41|issn=08898588|doi=10.1016/j.hoc.2012.10.004}}</ref>
* Cyclic neutropenia is caused by a mutation in the ELA2 gene.<ref name="HorwitzCorey2013">{{cite journal|last1=Horwitz|first1=Marshall S.|last2=Corey|first2=Seth J.|last3=Grimes|first3=H. Leighton|last4=Tidwell|first4=Timothy|title=ELANE Mutations in Cyclic and Severe Congenital Neutropenia|journal=Hematology/Oncology Clinics of North America|volume=27|issue=1|year=2013|pages=19–41|issn=08898588|doi=10.1016/j.hoc.2012.10.004}}</ref>
==Differentiating Cyclic neutropenia from Other Diseases==
==Differentiating Cyclic neutropenia from Other Diseases==
 
* Cyclic neutropenia should be differentiated from other disorders manifesting with recurrent [[fever]], [[aphthous stomatitis]], and [[pharyngitis]]. These include [[PFAPA syndrome]], and some of the monogenic [[autoinflammatory disorders]] such as [[FMF]], [[CAPS]], and [[TRAPS]].<ref name="AliSartori-Valinotti2016">{{cite journal|last1=Ali|first1=Nora S.|last2=Sartori-Valinotti|first2=Julio C.|last3=Bruce|first3=Alison J.|title=Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome|journal=Clinics in Dermatology|volume=34|issue=4|year=2016|pages=482–486|issn=0738081X|doi=10.1016/j.clindermatol.2016.02.021}}</ref>
* For more information on cyclic neutropenia [[differential diagnosis]] please [[Familial mediterranean fever differential diagnosis|click here]].
==Epidemiology and Demographics==
==Epidemiology and Demographics==
* The incidence of cyclic neutropenia is 0.010-0.02 per 100,000 individuals worldwide.<ref name="pmid14962902">{{cite journal |vauthors=Bellanné-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, Vaury C, Barkaoui M, Fenneteau O, Maier-Redelsperger M, Chomienne C, Donadieu J |title=Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register |journal=Blood |volume=103 |issue=11 |pages=4119–25 |date=June 2004 |pmid=14962902 |doi=10.1182/blood-2003-10-3518 |url=}}</ref>
* The incidence of cyclic neutropenia is 0.010-0.02 per 100,000 individuals worldwide.<ref name="pmid14962902">{{cite journal |vauthors=Bellanné-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, Vaury C, Barkaoui M, Fenneteau O, Maier-Redelsperger M, Chomienne C, Donadieu J |title=Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register |journal=Blood |volume=103 |issue=11 |pages=4119–25 |date=June 2004 |pmid=14962902 |doi=10.1182/blood-2003-10-3518 |url=}}</ref>

Revision as of 14:59, 24 September 2019

WikiDoc Resources for Cyclic neutropenia

Articles

Most recent articles on Cyclic neutropenia

Most cited articles on Cyclic neutropenia

Review articles on Cyclic neutropenia

Articles on Cyclic neutropenia in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Cyclic neutropenia

Images of Cyclic neutropenia

Photos of Cyclic neutropenia

Podcasts & MP3s on Cyclic neutropenia

Videos on Cyclic neutropenia

Evidence Based Medicine

Cochrane Collaboration on Cyclic neutropenia

Bandolier on Cyclic neutropenia

TRIP on Cyclic neutropenia

Clinical Trials

Ongoing Trials on Cyclic neutropenia at Clinical Trials.gov

Trial results on Cyclic neutropenia

Clinical Trials on Cyclic neutropenia at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Cyclic neutropenia

NICE Guidance on Cyclic neutropenia

NHS PRODIGY Guidance

FDA on Cyclic neutropenia

CDC on Cyclic neutropenia

Books

Books on Cyclic neutropenia

News

Cyclic neutropenia in the news

Be alerted to news on Cyclic neutropenia

News trends on Cyclic neutropenia

Commentary

Blogs on Cyclic neutropenia

Definitions

Definitions of Cyclic neutropenia

Patient Resources / Community

Patient resources on Cyclic neutropenia

Discussion groups on Cyclic neutropenia

Patient Handouts on Cyclic neutropenia

Directions to Hospitals Treating Cyclic neutropenia

Risk calculators and risk factors for Cyclic neutropenia

Healthcare Provider Resources

Symptoms of Cyclic neutropenia

Causes & Risk Factors for Cyclic neutropenia

Diagnostic studies for Cyclic neutropenia

Treatment of Cyclic neutropenia

Continuing Medical Education (CME)

CME Programs on Cyclic neutropenia

International

Cyclic neutropenia en Espanol

Cyclic neutropenia en Francais

Business

Cyclic neutropenia in the Marketplace

Patents on Cyclic neutropenia

Experimental / Informatics

List of terms related to Cyclic neutropenia

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Synonyms and keywords: Cyclic hematopoiesis

Overview

Cyclic neutropenia is a condition in which the neutrophil count periodically and regularly rises and falls. It is rarely observed in humans, but has been observed in the Grey Collie dog.

Historical Perspective

  • Cyclic neutropenia first described in the year 1910 in an infant with recurrent fever.[1]

Classification

  • There is no established system for the classification of cyclic neutropenia.

Pathophysiology

  • Cyclic neutropenia is caused by a mutation in the ELA2 gene.[1][2]
  • The disease occurs in autosomal dominant mode of inheritance.
  • Theoretically, this disorder can be cured by bone marrow transplantation. This demonstrates its pathogenesis as the stem cell abnormality.[3]
  • This stem cell abnormality leads to the myelocyte maturation arrest during neutropenia episodes.

Causes

  • Cyclic neutropenia is caused by a mutation in the ELA2 gene.[2]

Differentiating Cyclic neutropenia from Other Diseases

Epidemiology and Demographics

  • The incidence of cyclic neutropenia is 0.010-0.02 per 100,000 individuals worldwide.[5]

Risk Factors

  • There are no established risk factors for cyclic neutropenia.

Screening

  • There is insufficient evidence to recommend routine screening for cyclic neutropenia.

Natural History, Complications, and Prognosis

  • Disease manifests in early years of life with episodes of fever occurring every 21 days (range from 14 to 35 days).[6]
  • The hallmark of this disorder is the predictability of the fever episodes.
  • Patients may also present with gingivitis, stomatitis, and malaise.
  • During episodes, patients are neutropenic.

Diagnosis

Diagnostic Criteria

History and Symptoms

  • Symptoms of cyclic neutropenia include fever, malaise, oral ulcers, gingival inflammation, edema, and sore throat.[7][3]

Physical Examination

  • Physical examination of patients with cyclic neutropenia include:[7]
    • Fever
    • Pharyngitis
    • Gingival inflammation and edema

Laboratory Findings

  • Laboratory findings associated with the diagnosis of cyclic neutropenia include:
    • Low absolute neutrophilic count

Electrocardiogram

  • There are no ECG findings associated with cyclic neutropenia.

X-ray

  • There are no x-ray findings associated with cyclic neutropenia.

Echocardiography or Ultrasound

CT Scan

  • There are no CT scan findings associated with cyclic neutropenia.

MRI

  • There are no MRI findings associated with cyclic neutropenia.

Other Imaging Findings

  • There are no other imaging findings associated with cyclic neutropenia.

Other Diagnostic Studies

Treatment

Medical Therapy

  • The mainstay of treatment for cyclic neutropenia is medical therapy.[8][9]
  • Granulocyte colony-stimulating factor (G-CSF) may be used to treat cyclic neutropenia.

Surgery

  • Surgical intervention is not recommended for the management of cyclic neutropenia.

Primary Prevention

Secondary Prevention

References

  1. 1.0 1.1 Dale, David C.; Bolyard, Audrey Anna; Aprikyan, Andrew (2002). "Cyclic neutropenia". Seminars in Hematology. 39 (2): 89–94. doi:10.1053/shem.2002.31917. ISSN 0037-1963.
  2. 2.0 2.1 Horwitz, Marshall S.; Corey, Seth J.; Grimes, H. Leighton; Tidwell, Timothy (2013). "ELANE Mutations in Cyclic and Severe Congenital Neutropenia". Hematology/Oncology Clinics of North America. 27 (1): 19–41. doi:10.1016/j.hoc.2012.10.004. ISSN 0889-8588.
  3. 3.0 3.1 Lange RD, Jones JB (1981). "Cyclic neutropenia. Review of clinical manifestations and management". Am J Pediatr Hematol Oncol. 3 (4): 363–7. PMID 7036779.
  4. Ali, Nora S.; Sartori-Valinotti, Julio C.; Bruce, Alison J. (2016). "Periodic fever, aphthous stomatitis, pharyngitis, and adenitis (PFAPA) syndrome". Clinics in Dermatology. 34 (4): 482–486. doi:10.1016/j.clindermatol.2016.02.021. ISSN 0738-081X.
  5. Bellanné-Chantelot C, Clauin S, Leblanc T, Cassinat B, Rodrigues-Lima F, Beaufils S, Vaury C, Barkaoui M, Fenneteau O, Maier-Redelsperger M, Chomienne C, Donadieu J (June 2004). "Mutations in the ELA2 gene correlate with more severe expression of neutropenia: a study of 81 patients from the French Neutropenia Register". Blood. 103 (11): 4119–25. doi:10.1182/blood-2003-10-3518. PMID 14962902.
  6. Dale DC, Bolyard AA, Aprikyan A (April 2002). "Cyclic neutropenia". Semin. Hematol. 39 (2): 89–94. PMID 11957190.
  7. 7.0 7.1 Palmer SE, Stephens K, Dale DC (December 1996). "Genetics, phenotype, and natural history of autosomal dominant cyclic hematopoiesis". Am. J. Med. Genet. 66 (4): 413–22. doi:10.1002/(SICI)1096-8628(19961230)66:4<413::AID-AJMG5>3.0.CO;2-L. PMID 8989458.
  8. Hammond WP, Price TH, Souza LM, Dale DC (May 1989). "Treatment of cyclic neutropenia with granulocyte colony-stimulating factor". N. Engl. J. Med. 320 (20): 1306–11. doi:10.1056/NEJM198905183202003. PMID 2469956.
  9. Bonilla MA, Dale D, Zeidler C, Last L, Reiter A, Ruggeiro M, Davis M, Koci B, Hammond W, Gillio A (December 1994). "Long-term safety of treatment with recombinant human granulocyte colony-stimulating factor (r-metHuG-CSF) in patients with severe congenital neutropenias". Br. J. Haematol. 88 (4): 723–30. doi:10.1111/j.1365-2141.1994.tb05110.x. PMID 7529539.

Template:WS Template:WH